Tuesday, June 12, 2018

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; (TSX: $WEED.TO), (TSX: $TRST.TO), (CSE: $CRZ.C), (CSE: $IAN.C)

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; (TSX: $WEED.TO), (TSX: $TRST.TO), (CSE: $CRZ.C), (CSE: $IAN.C)

Pt. Roberts, WA; Delta, BC –June 12, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast – looking at cannabis news, stocks to watch as well as insights from thought leaders and experts. Today we are looking at announcements from Canopy Growth Corporation (TSX: WEED and NYSE: CGC), CannTrust Holdings Inc. (TSX: TRST), CannaRoyalty Corp. (CSE: CRZ and OTCQX: CNNRF) and iAnthus Capital Holdings, Inc. (CSE: IAN and OTCQB: ITHUF).

Canopy Growth Corporation provided updates on its medical cannabis program and re-affirmed its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it.

Marking a major milestone for medical cannabis in Canada, a Phase IIb "in-human" clinical trial application was submitted by Canopy Health Innovations Inc. to evaluate the use of medical cannabis in the treatment of insomnia. Having received approval to proceed with these clinical trials in the form of a No Objection Letter (NOL) from Health Canada, Canopy Health will now proceed with these robust clinical trials, in collaboration with a leading Canadian research institution.

Also, as previously announced, starting in July 2018, Dr. Mark Ware will commence his role as the Company's Chief Medical Officer. Under his leadership the Company will continue to lead the global medical cannabis industry forward with a focus on research, product innovation, and stakeholder education in the numerous regions where Spectrum Cannabis operates, including Latin America, Australia, Europe and North America.

Finally, in order to honor the company’s commitment to affordable medical cannabis and pricing predictability for patients, Canopy Growth announced that upon the passing of the Cannabis Act, the Company will absorb the proposed excise tax on all Spectrum Cannabis products sold in Canada. Affordability is a key consideration for patients. It is important today to show leadership and reduce the price burden placed on our customers,while we work towards insurance eligibility for medical cannabis. 
On top of this, all Spectrum Cannabis dried flower products will be priced at $8.50 per gram or less. If a registered customer is currently paying more for a Spectrum flower product this means new savings, and if they are paying less that price will remain the same. As always, Spectrum Cannabis products available online through TweedMainStreet.com are eligible for our industry-first Compassionate Pricing Program that assists those on limited incomes afford their medicine.

CannTrust Holdings Inc., one of Canada's leading licensed producers of medical cannabis, announced the signing of a memorandum of understanding with Niagara College to collaborate in the development of the College's Commercial Cannabis Production (CCP) Graduate Certificate program. The program will strengthen CannTrust's workforce production capabilities and help fill the growing demand for knowledgeable employees in the booming cannabis industry.

With the launch of this new program, Niagara College will become the first Canadian post-secondary institution to offer credits in Commercial Cannabis Production. CannTrust will be awarding six students with scholarships as part of the program's inauguration. The College and CannTrust are excited to be participating in shaping the future of Canada's cannabis industry and look forward to welcoming the program's first student intake in September 2018.

CannaRoyalty Corp., a leading North American cannabis products and brands company, announced today that its investee company Anandia Laboratories Inc. has signed a binding term sheet to be acquired by Aurora Cannabis Inc. for approximately $115 million. CannaRoyalty owns 16.5% of Anandia, and its equity stake is valued at approximately $19 million based on the acquisition valuation, representing an almost 400% return on investment.

This acquisition advances CannaRoyalty's stated strategy of partnering or rationalizing select assets that the Company has deemed non-core to its go-forward strategy and more valuable to other parties. The proceeds will be used to fund expansion and further acquisitions without dilution for shareholders and the acquisition by one of Canada's largest LPs validates the significant long-term potential that CannaRoyalty identified in the analytics, testing and genetics verticals.

iAnthus Capital Holdings, Inc., which owns, operates, and partners with licensed cannabis operations throughout the United States, announced today that Mayflower Medicinals, Inc. has signed a Host Community Agreement with the City of Lowell, Massachusetts, to operate a Medical Marijuana Treatment Center located at 450 Chelmsford Street. Lowell, Massachusetts.

Mayflower intends to diligently pursue a Special Permit at the site.  If granted, the dispensary is expected to be one of only two operating dispensaries within the Lowell city limits.

"The Commonwealth of Massachusetts and the City of Lowell have abided by high program standards that are firmly focused on patient care and regulatory compliance," said John Henderson, Chief Development Officer of iAnthus. "Mayflower is honored to have successfully completed its host community agreement with Lowell, which adds significant value to the project by documenting a supportive relationship between the City and the development of the Registered Marijuana Dispensary site."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Subscribe to the new cannabis podcast series:

To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

To sponsor this podcast or be a guest

Contact Investorideas.com


Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news

No comments:

Post a Comment